If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Thought Leader Services
Download FREE Excerpt
13 Info Graphics
11 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Key Opinion Leaders (KOLs) play a critical role in the clinical development and marketplace education of new biopharmaceutical products. Thus, KOL relationship management has emerged as a necessary and vital part of organizational success for the pharmaceutical sector.
In an effort to examine how leading pharmaceutical companies approach KOL management, this research by Best Practices, LLC identifies activities associated with maintaining effective KOL relationships, leading companies in KOL management and lessons learned in KOL management. Research findings provide industry metrics that can serve as a reference point for companies to improve their KOL management tactics.
Twenty-two benchmark survey respondents from 17 companies participated in this study. Nearly 33% are directors, senior directors or vice presidents, and 45% are based in the United States. The participants represent three different industries. About 68% work in medical and scientific affairs.
Biotech; Medical Device; Pharmaceutical; Health Care; Education; Science; Manufacturing; Consumer Products; Diagnostic; Chemical
Biogen Idec; Baxter Healthcare; Medtronic; Teva Pharmaceutical Industries Ltd; Ortho-Clinical Diagnostics; Torrent Pharmaceuticals Ltd.; Reliance Institute of Life Sciences; Lupin; Bayer; ViiV Healthcare; AstraZeneca; Onyx Pharmaceuticals; Johnson & Johnson; LEO Pharma; Abbvie; AUSA; Genentech